Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 7.03% | 67.01 | 0.0% | $1025.55m | |
| NVAX | Novavax, Inc. | 8.25% | 102.14 | 251.8% | $827.54m | |
| AMGN | Amgen, Inc. | 1.34% | 252.38 | 1.3% | $703.09m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.07% | 627.52 | 2.5% | $670.13m | |
| GILD | Gilead Sciences, Inc. | 1.01% | 77.09 | 1.0% | $637.17m | |
| BIIB | Biogen, Inc. | 0.61% | 280.58 | 1.6% | $605.23m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.58% | 296.16 | 1.9% | $478.28m | |
| VXRT | Vaxart, Inc. | 24.19% | 9.91 | 0.0% | $356.29m | |
| ILMN | Illumina, Inc. | 1.65% | 376.35 | 3.5% | $306.15m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.15% | 108.66 | 2.0% | $216.87m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 1.33% | 127.74 | 4.3% | $209.57m | |
| SGEN | Seattle Genetics, Inc. | 0.36% | 174.98 | 6.1% | $193.08m | |
| SRNE | Sorrento Therapeutics, Inc. | -0.63% | 8.01 | 1.8% | $191.66m | |
| IMMU | Immunomedics, Inc. | 1.50% | 41.94 | 11.0% | $179.66m | |
| BNTX | BioNTech SE | 10.27% | 77.59 | 0.0% | $172.63m |
Company Profile
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney disease. The firm also involves in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.